Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
1,682,178
-
Share change
-
+106,317
-
Total reported value
-
$1,682,000
-
Price per share
-
$1.00
-
Number of holders
-
14
-
Value change
-
+$97,213
-
Number of buys
-
6
-
Number of sells
-
5
Institutional Holders of AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) as of Q2 2022
As of 30 Jun 2022,
AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,682,178 shares.
The largest 10 holders included
Omnia Family Wealth, LLC, NEA Management Company, LLC, Hikari Power Ltd, WSFS CAPITAL MANAGEMENT, LLC, LPL Financial LLC, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA SECURITIES, LLC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.